Avricore Health Inc (AVCR.V) saw a significant drop in its stock price this week, reflecting ongoing market dynamics.
This week, Avricore Health Inc (AVCR.V) closed at C$0.05, down 8.33% on Friday. Despite this decline, the stock has remained stable over the past month and year-to-date, showing no change in overall performance.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
-15.38%
Beta
0.36
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
205.9%
Annualized
90-Day Vol
155.1%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.03 – C$0.11 |
| 60 trading days | C$0.06 | C$0.02 – C$0.15 |
| 90 trading days | C$0.06 | C$0.02 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the recent financing and expansion plans as potential long-term growth opportunities, while also keeping an eye on the current volatility in stock performance.
Avricore Health Inc's stock price declines by 8.33% this week.
With a market cap of C$7.58 million and a profit margin of 0.0%, the company faces challenges in proving its financial viability.
Bull case
The recent completion of a $1.254 million financing round could provide Avricore with the capital needed to enhance its HealthTab™ platform and expand further into the UK market.
Bear case
The stock's recent decline and low trading volume compared to its 20-day average may signal weak investor sentiment and concerns about profitability.
Advertisement
Recent Price Action
Avricore Health Inc (AVCR.V) experienced a notable drop of 8.33% in its stock price on Friday, closing at C$0.05. Over the past week, the stock has remained unchanged, indicating a stable performance despite the recent downturn.
Company News and Developments
While there haven't been major announcements this week, recent news indicates that Avricore Health successfully closed a $1.254 million financing round to support its expansion in the UK. The company has also been recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch, highlighting its innovative HealthTab™ platform.
Technical Picture
Currently, Avricore Health's stock is trading below its 50-day moving average (C$0.06) and 200-day moving average (C$0.06), indicating a bearish trend. The stock has a 52-week range of C$0.04 to C$0.10, with its current price at 9% of this range. The beta of 0.32 suggests lower volatility compared to the broader market, but the recent trading volume of 2,000 shares is significantly below the 20-day average of 35,128 shares, indicating potential investor disinterest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
